Work

Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment

Year: 2022

Type: article

Source: Pharmaceutical Research

DOI: 10.1007/s11095-022-03393-w

Authors: Ian E. Stewart, Phillip G. Durham, Jacob M. Sittenauer, Aranza P. Barreda, Grayson W. Stowell, Carmella Moody, Jeffery B. Mecham, Catherine Simpson, Sharon Daily, Sara E. Maloney, Mark D. Williams, Diana Severynse-Stevens, Anthony J. Hickey

Institutions: RTI International, University of North Carolina at Chapel Hill, CritiTech (United States)

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, National Institute of Allergy and Infectious Diseases

Awards: Inhaled Caprazamycin for Tuberculolsis Therapy, Development of Inhaled CPZEN-45 For Tuberculosis Therapy

OpenAlex ID: W4295997730

FWCI: 1.128

Cites: 18

Cited by: 7

Related to: 10